Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Application value and safety of trilaciclib in first-line chemotherapy combined with immunotherapy for extensive-stage small cell lung cancer: A real-world study.
Journal: Oncology letters
Published: May 23, 2025
Properties of FDA-approved small molecule protein kinase inhibitors: A 2025 update.
Journal: Pharmacological research
Published: March 29, 2025
HSR25-156: Myelosuppression and Healthcare Resource Utilization in Community Oncology Patients With Limited-Stage Small Cell Lung Cancer (LS-SCLC) Receiving First-Line Therapy With or Without Trilaciclib.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
Cost-effectiveness analysis of trilaciclib for reducing the incidence of chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer in China.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: March 10, 2025
Real-World Clinical Outcomes of Trilaciclib for the Prevention of Myelosuppression in Patients with Esophageal Cancer Undergoing Chemotherapy.
Journal: Current oncology (Toronto, Ont.)
Published: February 11, 2025
Discovery of Potent and Selective CDK4/6 Inhibitors for the Treatment of Chemotherapy-Induced Myelosuppression.
Journal: Journal of medicinal chemistry
Published: January 06, 2025
Real-World Assessment of Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study.
Journal: Cancer medicine
Published: November 12, 2024
Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer.
Journal: Chinese clinical oncology
Published: October 30, 2024
Synthesis and Acetylcholinesterase Inhibitory Activity of Novel Trilaciclib Analogs.
Journal: Chemistry & biodiversity
Published: August 01, 2024
Effect of trilaciclib administered before chemotherapy in patients with extensive-stage small-cell lung cancer: A pooled analysis of four randomized studies.
Journal: Cancer treatment and research communications
Published: July 25, 2024
Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial.
Journal: JNCI cancer spectrum
Published: July 08, 2024
Last Updated: 10/31/2025